Self-medication is gaining significant traction among the French, though it still trails behind some European neighbors like the UK. According to a 2016 Afipa report (French Association of the Pharmaceutical Industry for Responsible Self-Medication), sales of non-prescription, non-reimbursed medications grew by 3.3%. The broader self-care market—including drugs, medical devices, and non-prescription supplements—saw even stronger growth at 4.8%. Notably, 80% of French adults report practicing self-medication, with 92% viewing it as effective*.
Key drivers include familiarity with treatments for common symptoms (72%), the need for quick relief (66%), avoiding unnecessary strain on health insurance (30%), saving time on doctor visits or lacking availability (24% and 23%), and low confidence in doctors or reluctance to discuss symptoms (3% each). The practice shows strong seasonality, peaking notably in winter. Health professionals—doctors and pharmacists alike—acknowledge this upward trend continuing for years. While 95% of pharmacists and 94% of physicians warn of risks without oversight**, they also highlight benefits: reduced healthcare costs, lighter doctor workloads, and more focus on serious or chronic conditions.
In essence, self-medication works best with guidance from trusted health experts who can address your questions. Are you already on board?
* 60 Million Consumers study, December 2015.
** Ipsos study, December 2016.
